Diane Stroehmann serves as Executive at Sienna Biopharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Diane Stroehmann has executed 4 insider transactions totaling $105.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 2, 2019 involved selling 4,095 shares valued at $3.1K.
Diane Stroehmann currently holds 168,545 shares of Sienna Biopharmaceuticals, Inc. (SNNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Diane Stroehmann has been a net buyer of SNNA stock. They have purchased $105.0K and sold $0 worth of shares.
Diane Stroehmann's most recent insider trade was on Jul 2, 2019, when they sold 4,095 shares at $0.76 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 1, 2017 | SNNA | $105.0K | Purchase | 7,000 | $15.00 | Discretionary |
| Aug 1, 2017 | SNNA | $0 | Conversion | 28,153 | $N/A | Discretionary |